With the global economic growth slowing, Morgan Stanley in its research report has revised India's GDP growth estimates to 7.2 percent in FY23 from 7.6 percent and 6.4 percent for FY24 from 6.7 percent.
Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
EXAMIANS